India  

Covid: Covaxin regular emergency use; Maharashtra’s ‘worrisome’ situation

Video Credit: HT Digital Content - Duration: 02:59s - Published
Covid: Covaxin regular emergency use; Maharashtra’s ‘worrisome’ situation

Covid: Covaxin regular emergency use; Maharashtra’s ‘worrisome’ situation

Expressing concern over the rise in active COVID-19 cases in a few states, including Maharashtra, the Centre on Thursday advised people to be "careful and watchful" and not lower guard as the pandemic is not yet over.

At a press conference, NITI Aayog member (Health) V K Paul termed the coronavirus situation, especially in Maharashtra, "worrisome".

"We are very worried about the rise in cases in Maharashtra.

Don't take this virus for granted.

It can come up unexpectedly.

If we have to remain free of this virus, COVID-appropriate behavior, containment strategy as well as vaccination has to be brought in," Paul said.

Watch the full video for more details.


You Might Like


💡 newsR Knowledge: Other News Mentions

Maharashtra Maharashtra State in Western India

Maharashtra reports 67,123, Karnataka registers 17,489 COVID cases [Video]

Maharashtra reports 67,123, Karnataka registers 17,489 COVID cases

Maharashtra reported 67,123 fresh COVID cases, 56,783 discharges, and 419 deaths on April 17. While Maharashtra's capital reported 8,834 new COVID-19 cases, 6,617 discharges and 52 deaths in last 24 hours. On the other side, Karnataka today registered 17,489 new positive cases, 5,565 discharges and 80 deaths. Kerala also reported 13,835 new cases, 3654 recoveries and 27 deaths today. Meanwhile, Madhya Pradesh reported 11,269 new coronavirus cases, 6,497 recoveries, and 66 deaths in last 24 hours.

Credit: ANI    Duration: 01:22Published

Ten states/UTs account for 79.32% of new Covid-19 cases: Health ministry

Sixteen states and UTs -- Maharashtra, Chhattisgarh, Uttar Pradesh, Karnataka, Haryana, Rajasthan, Punjab, Kerala, Delhi, Tamil Nadu, Madhya Pradesh, Gujarat,..
IndiaTimes
Lokmanya Tilak Terminus remains crowded [Video]

Lokmanya Tilak Terminus remains crowded

While lockdown-like restrictions are in place in Maharashtra, Lokmanya Tilak Terminus remains crowded. Several migrant workers await their respective trains outside the station. Restrictions were imposed in view of rising COVID cases in Maharashtra.

Credit: ANI    Duration: 01:51Published

COVID-19 COVID-19 Disease caused by severe acute respiratory syndrome coronavirus 2

Kiren Rijiju tests positive for COVID-19 [Video]

Kiren Rijiju tests positive for COVID-19

Union Sports Minister Kiren Rijiju has tested positive for COVID-19. He took to Twitter handle and shared the information that he has tested positive for the virus. He is in self-isolation.

Credit: ANI    Duration: 01:04Published

'India defeated COVID-19 last year, can do it again': PM Modi at review meet - Key points

Prime Minister Narendra Modi on Saturday chaired a meeting to review the status of preparedness to handle the ongoing Covid-19 pandemic.
DNA

BBV152 BBV152 Vaccine against COVID-19

Covaxin production to be increased to 100 million doses per month by September 2021: Centre

Union health minister Harsh Vardhan said financial support is being provided to four manufacturers to expand Covaxin vaccine production.
DNA

India to increase Covaxin production to 100 million doses per month by September

The Union government on Friday said it will amp up the production of the indigenously developed Covaxin vaccine to 100 million doses per month by September. As..
IndiaTimes
Mumbai's Haffkine Institute gets Centre's nod to produce Covaxin [Video]

Mumbai's Haffkine Institute gets Centre's nod to produce Covaxin

The Central Government has given permission to Haffkine Institute to produce Bharat Biotech's Covaxin. CM Uddhav Thackeray thanked PM Modi through a tweet by CM office, Maharashtra on April 15, "The Dept of Science and Technology, Government of India, has granted approval to Haffkine Institute to produce Bharat Biotech's Covaxin vaccine on a transfer of technology basis. CM Uddhav Balasaheb Thackeray has thanked the Hon'ble PM Shri@narendramodi for approving this request."

Credit: ANI    Duration: 01:14Published

NITI Aayog NITI Aayog Indian government think tank

Remdesivir for those who are hospitalized, not to be procured from chemist shops: Niti Aayog [Video]

Remdesivir for those who are hospitalized, not to be procured from chemist shops: Niti Aayog

During press conference held in Delhi, Niti Aayog's Dr VK Paul spoke on Remdesivir, which is an anti-viral drug for COVID-19. "There is no question of use of Remdesivir in home setting. This is required for those individuals who require hospitalisation and are on oxygen. It should only be use in hospital and not to be procured from chemist shops. We appeal that there should be rational use of Remdesivir. The drug is available in sufficient numbers. We appeal to the physicians' community for rational, judicious, and correct use of the drug," said Dr VK Paul.

Credit: ANI    Duration: 02:26Published
‘Doses approved by US regulators…’: Centre on vaccines, Remdesivir use | Covid [Video]

‘Doses approved by US regulators…’: Centre on vaccines, Remdesivir use | Covid

The Centre on Tuesday said doctors should ensure "rational and judicious" use of anti-viral drug Remdesivir, underlining it is to be given only to serious COVID-19 patients in hospitals and is not to be used in home settings. NITI Aayog member (Health) Dr V K Paul said, "Remdesivir is to be used only in those who require hospitalisation and are on oxygen support. That is the precondition. There is no question of its use in the home setting and for mild cases, and it is not to be procured from chemist shops." "We appeal to physicians to ensure rational, correct and judicious use of Remdesivir in hospitalised patients," he said. Watch the full video for more details.

Credit: HT Digital Content    Duration: 06:23Published

Remdesivir 'not for home use', Centre says amid rise in demand

Addressing a media briefing on Tuesday, Niti Aayog member Dr V K Paul said Remdesivir is "only for those who require hospitalisation and oxygen. That is the..
IndiaTimes
No vaccine shortage in country: NITI Aayog [Video]

No vaccine shortage in country: NITI Aayog

While addressing a joint press conference in the national capital on March 24, the member of (Health) in NITI Aayog, Dr Vinod K Paul said there is no shortage of COVID vaccines in the country. Dr Paul said, "We have adequate supplies of vaccine for the COVID-19 vaccination program that has been brought forth." "There is no inadequacy of vaccine supply," he added.

Credit: ANI    Duration: 01:26Published

Related videos from verified sources

Watch: COVID patients share beds at Nagpur hospital amid case surge [Video]

Watch: COVID patients share beds at Nagpur hospital amid case surge

In a viral video, COVID-19 patient were seen sharing beds at Government Medical College and Hospital, Nagpur. This comes at a time when the country, is dealing with the second wave of coronavirus...

Credit: ANI     Duration: 02:23Published
Covid update: Experts on Covaxin use; Maharashtra CM on lockdown decision [Video]

Covid update: Experts on Covaxin use; Maharashtra CM on lockdown decision

From Bombay HC responding to PIL over vaccination to Covaxin’s use in India, here are the top updates on the coronavirus pandemic. Bombay High Court termed “selfish” a PIL which sought..

Credit: HT Digital Content     Duration: 02:42Published